NQO2 Press Articles
Daily Post; Liverpool (UK) - Cancer drug patent
Saturday 31st of July 2010 04:57:36 AM
Posted by admin / Under NQO2
| March 25, 2005 -- A RUNCORN firm is aiming to grab a slice of a pounds 1bn cancer treatment market. Biotechnology company Protherics yesterday... |
Pharma Marketletter - Protherics reviews early stage portfolio
Saturday 31st of July 2010 04:57:36 AM
Posted by admin / Under NQO2
| October 4, 2004 -- UK-based biopharmaceutical company Protherics says it has transferred the former Enact Pharma R&D function at Porton Down and out-licensed and... |



